What is Regulatory Strategy & Compliance?
Regulatory strategy and compliance play a pivotal role in the success of life sciences startups. Our team excels in providing targeted guidance and support, ensuring your life sciences venture aligns with best practices and regulatory standards, bolstering its reputation and instilling trust among investors and stakeholders. Through meticulous execution, we help you navigate the intricate regulatory requirements and filings of specific therapeutic areas for the health regulatory body of your choosing, positioning your organization as a reliable and compliant player in the industry.
Key Focus Areas:
- Tailored Regulatory Plans: We work with you to customize a regulatory strategy to determine a pathway for the class of your pharmaceutical, medical device, diagnostic, natural health product, or related products.
- Regulatory Filing Solutions: Our compliance experience includes preparing domestic and international regulatory applications and facilitating submissions to the health regulator, providing you with end-to-end support throughout the entire product lifecycle.
- Regulatory Intelligence: API remains updated on the latest regulatory developments to provide proactive and informed strategies for regulatory compliance.

Benefits of Regulatory Strategy & Compliance
In a landscape where compliance is paramount for safe and successful health outcomes, partnering with API for your life sciences regulatory strategy brings several advantages:
- Regulatory Confidence: You not only have a partner to navigate complex regulations, but also to help build confidence among your stakeholders and investors, knowing your regulatory strategy is compliant with national and international regulations and relevant GxP standards.
- Risk Mitigation: Work with us to proactively identify and mitigate risks, safeguarding your products and ensuring regulatory success.
- Faster Product Approvals: Our proactive regulatory strategies streamline your submissions, as our team finds and navigates the right pathways to expedite the approval process for new drugs, medical devices, and natural health products.
- Safety & Integrity: From patient safety to data integrity, API’s team of SMEs prioritizes ethical compliance. We are committed to adhering to ICH guidelines, and you can rest assured our regulatory solutions follow Good Clinical Practice (GCP), Good Manufacturing Practice (GMP) standards, and more.
- Collaborative Success: We respond to regulatory queries and address concerns raised by health regulatory bodies during the review process. This includes liaising with regulatory agencies such as the FDA, EMA, MHRA, Health Canada and others.
- Market Access: Leverage our regulatory expertise to help realize the commercialization of your products in North America, with our track record and experience in Canada and the US.

Regulatory Strategy & Compliance Team

Launa Aspeslet
Chief Translational Officer
Read bioabout Launa Aspeslet
Launa Aspeslet
Chief Translational Officer
Launa Aspeslet is an accomplished life science executive and board member with over 20 years of leadership experience in scaling early-stage organizations to sustainable growth and maturity. She excels in multi-stakeholder environments, new product development, and guiding entrepreneurs through organizational transformation.
Currently, Launa also serves as Senior Clinical & Regulatory Advisor to Model Medicines and a Board member of Edmonton Unlimited. She recently acted as interim CEO at Edmonton Unlimited and has held roles as COO at Hepion Pharmaceuticals, CEO of TRIO, and COO at Isotechnika Pharma. She has also provided strategic consulting for various early-stage drug and medical device companies. During this time, Launa has led teams to conduct over 50 clinical trials, enrolling more than 10,000 patients across 20 countries.
She holds a BSc in chemistry from the University of Lethbridge and a PhD in Pharmaceutical Sciences from the University of Alberta, along with a Regulatory Affairs Certification (RAC).

Julianna Weber
Director, Commercial Operations

Vijay Somayaji
Sr. Director, Product Development & Quality
Read bioabout Vijay Somayaji
Vijay Somayaji
Sr. Director, Product Development & Quality
Vijay has over 30 years experience in biotech research and development and QA/QC. With a PhD in Chemistry and post-doctoral work under Nobel Laureate Dr. H. C. Brown, Vijay has served in director level roles at Biomira, AltaRex, Novolytic, and Virexx. As an experienced QA, Vijay has supported product development for dozens of clinical programs taking place at sites around the world.

John Huang
Regulatory Affairs Specialist

Bronsen Kwong
Product Manager Associate
Ready to take your life sciences innovation to the next level?
Contact us today for a free discovery consultation to determine how we can bring your idea to market together.
Related Services
Clinical Strategy & Services
Our clinical expertise at API spans pharmaceuticals and biologics, medical devices…
Biostatistical Analysis
API offers strategic support through robust biostatistical analysis to extract meaningful insights and…